• Corpus ID: 27261268

DYNAMICS OF HYPERLIPIDEMIA AND PERIPHERAL BLOOD FLOW IN PATIENTS WITH DIABETES MELLITUS AFTER THE COURSE OF COMBINED LASER THERAPY IN AMBULATORY -

@inproceedings{Kovalyova2006DYNAMICSOH,
  title={DYNAMICS OF HYPERLIPIDEMIA AND PERIPHERAL BLOOD FLOW IN PATIENTS WITH DIABETES MELLITUS AFTER THE COURSE OF COMBINED LASER THERAPY IN AMBULATORY -},
  author={Tetiana Kovalyova and A. V. Farvayeva and L. T. Pimenov},
  year={2006}
}
The study demonstrates that hypercholesterinemia in patients with coronary heart disease (CHD) is associated with functional depression of microcirculation, increase in total peripheral vascular resistance, reduction in the functional efficiency of heart and decrease in activity tolerance. After receiving a course of low-intensity infrared laser radiation treatment the patients displayed positive changes in blood lipid spectrum, which was associated with improvement in microcirculation… 
1 Citations

Tables from this paper

Effect of Blue Laser Intranasal Irradiation on Hyperlipidemia in Patients with Coronary Atherosclerosis

It was concluded that intranasal blue laser blood irradiation adds no extra benefits other than those gained by Statins therapy, while managing lipid profile in atherosclerotic patients.

References

SHOWING 1-10 OF 26 REFERENCES

The dyslipoproteinemias of diabetes.

It is reasonable to postulate that treating the dyslipoproteinemias of diabetes would reduce atherosclerotic disease, but to date there have been no intervention studies specifically designed to test this postulate in the diabetic population.

The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with type 2 (non-insulin-dependent) diabetes mellitus: A prospective study

It is concluded that intensive dietary therapy may lead to a less atherogenic lipid profile in Type 2 diabetes, particularly in patients who achieve a major weight reduction.

Diabetes and atherosclerosis: an epidemiologic view.

Only a relatively small proportion of the excessive occurrence of ASVD in diabetics can be explained by the effects of diabetes on the levels of general risk factors for ASVD, but the major proportion remains unexplained and must be due to effects of Diabetes itself through mechanisms that are incompletely understood.

Diabetes and Cardiovascular Risk Factors: The Framingham Study

The role of diabetes as a cardiovascular risk factor does not derive from an altered ability to contend with known risk factors and there is no indication that the relationship of risk factors to the subsequent development of cardiovascular disease is different for diabetics and non-diabetics.

Hypercholesterolemia in Diabetes and Glucose Intolerance in the U.S. Population

Investigation of blood lipid levels and coronary heart disease risk factors should be routine in all patients with diabetes, and treatment strategies should include management of lipid disorders and the multiple other risk factors for coronaryHeart disease that are highly prevalent in these patients.

Mortality and associated risk factors in diabetics.

In 168 male diabetics aged 40-64 years participating in the Whitehall Study, ten-year age adjusted mortality rates were significantly higher than in non-diabetics for all causes, coronary heart

Changes in High Density Lipoprotein Cholesterol After Initiation of Insulin Therepy in Non‐Insulin Dependent Diabetes Mellitus: Relationship toChanges in Body Weight

Insulin therapy of diabetes mellitus favorably affects HDL-C concentration perhaps by altering triglyceride metabolism and represents a unique situation where increases in body weight are associated with increases in serum HDL- C concentration.

Quantitative and Qualitative Lipoprotein Abnormalities in Diabetes Mellitus

It has been questioned whether the target values to start treatment should be lower in diabetic than in nondiabetic populations, because alterations in the concentrations of major lipids and lipoproteins are well characterized in both IDDM and NIDDM.

Dyslipidemia and Hyperglycemia Predict Coronary Heart Disease Events in Middle-Aged Patients With NIDDM

Evidence is provided that dyslipidemia and poor glycemic control predict CHD mortality and morbidity in patients with NIDDM, and a 7-year follow-up study on risk factors for CHD provides evidence.